X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-10 | MYOV | Sumitomo Chemical Co., Ltd. | 10% | P - Purchase | $27.00 | +51,599,200 | 45,798,176 | -889% | +$1,393,178,400 | ||||||
2023-01-18 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $26.89 | -1,272 | 354,303 | 0% | -$34,204 | ||||||
2023-01-18 | MYOV | Merendino Lauren | Chief Commercial Officer | S - Sale | $26.89 | -2,008 | 169,538 | -1% | -$53,995 | ||||||
2023-01-18 | MYOV | Marek David C | Principal Exec Officer | S - Sale | $26.89 | -8,037 | 417,599 | -2% | -$216,115 | ||||||
2023-01-18 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $26.89 | -1,109 | 246,684 | 0% | -$29,821 | ||||||
2023-01-04 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $26.90 | -2,251 | 247,793 | -1% | -$60,552 | ||||||
2023-01-04 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $26.90 | -2,779 | 355,575 | -1% | -$74,755 | ||||||
2022-12-16 | MYOV | Mehra Uneek | Principal Financial Officer | S - Sale | $26.75 | -2,241 | 202,696 | -1% | -$59,947 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |